Profiling Drug Susceptibility and Species Identification of Aspergillus Isolates From Patients With Superficial Infection
Mycoses · 2025
DOI: 10.1111/myc.70059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mycoses, 2025. Verfasst von Yahui Feng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medical Mycology, The No. 1 People's Hospital of Jining, Jining, Shandong, China. Hauptthemen laut MEDLINE: Antifungal Agents, Aspergillus, Aspergillosis. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Key R&D Program of Jining, National Natural Science Foundation of China, Traditional Chinese Medicine Science and Technology Program of Shandong Province.
Abstract (Originalsprache)
Background
Aspergillus infections pose significant challenges in clinical management due to rising resistance rates and limited diagnostic accuracy. Superficial infections, particularly in immunocompetent individuals, are often understudied, despite their prevalence in specific populations.
Objectives
This study aimed to characterise the distribution and antifungal susceptibility patterns of Aspergillus isolates from a tertiary hospital in Shandong, China, and evaluate the performance of matrix‐assisted laser desorption time‐of‐flight (MALDI‐TOF) mass spectrometry versus multi‐gene sequencing for species identification. Patients/Methods A total of 120 Aspergillus isolates were collected from patients with localised aspergillosis (nails, external auditory canal, cornea, sub‐throat secretions) between 2020 and 2021. Species identification was performed using MALDI‐TOF and multi‐gene sequencing (ITS, BenA, CaM, RPB2). Antifungal susceptibility testing was conducted for micafungin, azoles (itraconazole, voriconazole, posaconazole, fluconazole), and amphotericin B following standard protocols.
Results
Species Identification: MALDI‐TOF identified 52.5% of isolates to the species level, whereas multi‐gene sequencing achieved 100% accuracy. Aspergillus terreus was the most prevalent species (38.3%). Antifungal Susceptibility: Micafungin showed the highest resistance rate (40%), followed by amphotericin B (reduced susceptibility in 31.7%). Azoles demonstrated low resistance (3.3%–6.7%) except for fluconazole (21.7%). Clinical Correlates: Superficial infections were most common in middle‐aged/elderly patients (68.3%), frequently linked to external trauma (41.7%) or environmental exposure (35.8%).
Conclusions
Multi‐gene sequencing outperformed MALDI‐TOF for Aspergillus identification. A. terreus dominance and micafungin resistance highlight regional epidemiological trends. Natamycin and nystatin remain cost‐effective first‐line topical options. Enhanced surveillance in trauma‐prone and environmentally exposed populations is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Medical Mycology, The No. 1 People's Hospital of Jining, Jining, Shandong, China.
- Department of Otolaryngology, The PKU Care Luzhong Hospital of Zibo, Zibo, Shandong, China.
- Department of Dermatology, Shanghai Key Laboratory of Molecular Medical Mycology, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China.
- Shandong First Medical University, Jinan, Shandong, China.
- Department of Microbiology and Immunology, School of Medicine, Georgetown University, Washington, DC, USA.
- Department of Medical Laboratory, The No. 1 People's Hospital of Jining, Zibo, Shandong, China.
ORCID-Profile: Dongmei Shi
Förderung
- Key R&D Program of Jining
- National Natural Science Foundation of China
- Traditional Chinese Medicine Science and Technology Program of Shandong Province
Zitieren
APA
Feng, Y., Zhang, Z., Fang, W., Wang, S., Zhang, J., Li, D., Liao, W., Li, R., & Shi, D. (2025). Profiling Drug Susceptibility and Species Identification of Aspergillus Isolates From Patients With Superficial Infection. Mycoses. https://doi.org/10.1111/myc.70059
Vancouver
Feng Y, Zhang Z, Fang W, Wang S, Zhang J, Li D, et al. Profiling Drug Susceptibility and Species Identification of Aspergillus Isolates From Patients With Superficial Infection. Mycoses. 2025. doi:10.1111/myc.70059
BibTeX
@article{Feng2025,
author = {Feng, Yahui and Zhang, Zhichao and Fang, Wenjie and Wang, Sisi and Zhang, Jianfeng and Li, Dongmei and Liao, Wanqing and Li, Renzhe and Shi, Dongmei},
title = {Profiling Drug Susceptibility and Species Identification of Aspergillus Isolates From Patients With Superficial Infection},
journal = {Mycoses},
year = {2025},
doi = {10.1111/myc.70059}
}
EUVIMED